FDA Orange Book · active-ingredient family
Penicillin g sodium
Penicillin g sodium is approved in 5 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
0
Brand (NDA)
5
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Generic (ANDA) products (5)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PENICILLIN G SODIUM | SANDOZ | ANDA 065068 | — | Feb 26, 2001 | |
| PENICILLIN G SODIUM | WATSON LABS INC | ANDA 063014 | — | Sep 13, 1988 | |
| PENICILLIN G SODIUM | BRISTOL MYERS SQUIBB | ANDA 061935 | — | Approved Prior to Jan 1, 1982 | |
| PENICILLIN G SODIUM | COPANOS | ANDA 061051 | — | Approved Prior to Jan 1, 1982 | |
| PENICILLIN G SODIUM | PHARMACIA AND UPJOHN | ANDA 061046 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Penicillin g sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
